The Current Status of GLP-1s in Canada Health Canada has approved several GLP-1 medications for use
as of May 2026 is clinical trial enrollment FDA-approved alternatives exist (semaglutide, tirzepatide) with established compounding and dosing pathways and substantial clinical data Self-sourcing research peptides for human use is not safe and carries identity, purity, and contamination risks If you are a clinician: Patient questions about retatrutide source verification are increasing
Your RFC is a set of restrictions on what work activities you can do
RNA-bound PGC-1 controls gene expression in liquid-like nuclear condensates, Proceedings of the National Academy of Sciences, (2021), 118
Third parties operate under their own terms and privacy practices
It also slows stomach emptying, which helps reduce hunger and calorie intake